arrow
Á

Ángel Gustavo Salas-Lais

Instituto Mexicano del Seguro Social
H指数:10
被引数:281

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Post-Pandemic Genomic Diversity and Lineage Turnover of Influenza Viruses in Mexico During 2022–2023

2022–2023年墨西哥流感病毒的后疫情基因组多样性与谱系更替

Viruses
IF3.5
2026-05-280
OA
Measles, Rubella, and Mumps in Mexico: A National Serosurvey Highlighting Reemergence Risks

麻疹、风疹和流行性腮腺炎在墨西哥:一项凸显再发风险的国家血清调查

2026-04-250
PRE
Exploration of low- frequency allelic variants of SARS- CoV-2 genomes reveals coinfections in Mexico occurred during periods of VOCs turnover

对传染性非典型肺炎CoV-2基因组的低频等位基因变体的探索揭示了墨西哥在voc周转期间发生的共感染

2024-03-210
OAAI
SARS-CoV-2 Omicron variants BA.4 and BA.5 dominated the fifth COVID-19 epidemiological wave in Mexico

SARS-CoV-2 Omicron变体BA.4和BA.5在墨西哥的第五次COVID-19流行病学浪潮中占主导地位

2023-12-192
OAAI
Overview of the SARS-CoV-2 genotypes circulating in Latin America during 2021
2023-03-027
OAAI
Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population
2023-02-145
OAAI
Omicron-BA.1 Dispersion Rates in Mexico Varied According to the Regional Epidemic Patterns and the Diversity of Local Delta Subvariants
2023-01-156
OAAI
Two-year follow-up of the COVID-19 pandemic in Mexico
2023-01-1315
OAAI
Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico
2022-05-2716
OAAI
The Alpha Variant (B.1.1.7) of SARS-CoV-2 Failed to Become Dominant in Mexico
2022-04-2718
OAAI
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
2021-04-1520
OAAI